Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Millennium Pharmaceuticals, Inc.
Scientific Title
A Phase 3, Randomized, Placebo-Controlled, Double-Blind Study of Oral Ixazomib Maintenance Therapy After Initial Therapy in Patients With Newly Diagnosed Multiple Myeloma Not Treated With Stem Cell Transplantation